Product Profile of Raloxifene Tablet for Increase in Estrogen Levels
Kee Pharma manufactures Raloxifene Tablet for Increase in Estrogen Levels. Kee Pharma is an ISO 9002 accredited company. The Raloxifene Tablet for Increase in Estrogen Levels is a selective estrogen receptor modulator that belongs to the benzothiophene class of compounds. Raloxifene`s biological actions, like those of estrogen, are mediated through binding to estrogen receptors. This binding results in differential expression of multiple estrogen-regulated genes in different tissues. Raloxifene is absorbed rapidly after oral administration. Approximately 60% of an oral dose is absorbed, but presystemic glucuronide conjugation is extensive. Absolute bioavailability of raloxifene is 2.0%.
